Zentalis Pharmaceuticals (ZNTL) Tax Provisions (2019 - 2026)
Zentalis Pharmaceuticals' (ZNTL) quarterly Tax Provisions came in at $120000.0 in Q1 2026, down 72.85% quarter-over-quarter from $442000.0 in Q4 2025.
Zentalis Pharmaceuticals (ZNTL) Tax Provisions (2019 - 2026) Analysis & Trends
Zentalis Pharmaceuticals' Tax Provisions history runs 8 years deep, the most recent figure standing at $120000.0 for Q1 2026.
- On a quarterly basis, Tax Provisions changed N/A year-over-year to $120000.0 in Q1 2026; TTM through Mar 2026 was $562000.0, a 1552.94% increase from a year earlier, with the FY2025 full-year figure at $442000.0, up 149.72% from the prior year.
- Tax Provisions slipped to $120000.0 in Q1 2026 per ZNTL's latest filing, from $442000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $442000.0 in Q4 2025 and bottomed at -$605000.0 in Q2 2023.
- The 5-year median for Tax Provisions is $24000.0 (2022), against an average of -$23642.9.
- Across the five-year window, Tax Provisions tumbled 3658.82% in 2023 and soared 315.61% in 2025, its largest moves.
- Year by year, Tax Provisions stood at -$360000.0 in 2022, then surged by 62.5% to -$135000.0 in 2023, then slumped by 51.85% to -$205000.0 in 2024, then surged by 315.61% to $442000.0 in 2025, then tumbled by 72.85% to $120000.0 in 2026.
- Per Business Quant, the three latest ZNTL Tax Provisions figures stand at $120000.0 (Q1 2026), $442000.0 (Q4 2025), and -$205000.0 (Q4 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Zentalis Pharmaceuticals | 302.14 Mn | 302.14 Mn | - | 120,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 120,000.00 |
| Dec 31, 2025 | 442,000.00 |
| Dec 31, 2024 | -205,000.00 |
| Sep 30, 2024 | -27,000.00 |
| Jun 30, 2024 | 266,000.00 |
| Mar 31, 2024 | 143,000.00 |
| Dec 31, 2023 | -135,000.00 |
| Sep 30, 2023 | 31,000.00 |
| Jun 30, 2023 | -605,000.00 |
| Mar 31, 2023 | 108,000.00 |
| Dec 31, 2022 | -360,000.00 |
| Sep 30, 2022 | -159,000.00 |
| Jun 30, 2022 | 17,000.00 |
| Mar 31, 2022 | 33,000.00 |
| Dec 31, 2021 | 159,000.00 |
| Sep 30, 2021 | -697,000.00 |
| Jun 30, 2021 | 45,000.00 |
| Mar 31, 2021 | 196,000.00 |
| Dec 31, 2020 | 426,000.00 |
| Sep 30, 2020 | 18,000.00 |